Mogamulizumab [1159266-37-1]

TargetMol Chemicals

Mogamulizumab

9

1159266-37-1

Antibody

Research Use Only

Mogamulizumab

SDS-PAGE:97.3%;SEC-HPLC:99.4%

Mogamulizumab (KW-0761) is a monoclonal antibody targeting T cell CC chemokine receptor 4. It exhibits anticancer activity by eliminating tumor cells through antibody-dependent cytotoxicity (ADCC) and can be used in the study of cancer, adult T-cell leukemia/lymphoma (ATLL), and cutaneous T-cell lymphoma (CTCL).

3 years

-20°C

12352203